Zhenghui (Alan) Wang, Ph.D.

Zhenghui (Alan) Wang, Ph.D.

Zhenghui (Alan) Wang, Ph.D.

Alan Wang is a counsel in the firm’s Technology and Life Sciences groups.

Dr. Wang represents pharmaceutical, biotechnology, diagnostic and medical device companies in domestic and cross-border complex life sciences and technology transactions, including co-development, licensing and collaboration, manufacturing, supply and distribution, M&A and other intellectual property transactions.
Areas of Practice
Domaines D’Expertise





  • A leading biotechnology company in collaboration with a multinational pharmaceutical company to develop, manufacture and distribute advanced antibody products for the treatment and prevention of COVID-19.*
  • A multinational pharmaceutical company in collaboration with a U.S. biotechnology company for potential therapeutics and vaccines against COVID-19.*
  • A multinational pharmaceutical company in a global license and collaboration arrangement with a clinical-stage public biotech company in China for anticancer inhibitor products.*
  • A UK pharmaceutical company in the divestiture of its rights related to a prescription opioid medicine in China.* 
  • A South Korean e-commerce company, in a sale of its Japanese business platform to a U.S. multinational e-commerce corporation.*
*Denotes experience prior to joining Goodwin.
Professional Experience

Prior to joining Goodwin, Dr. Wang was at another leading international law firm, where he focused on representing multinational pharmaceutical companies and biotechnology companies in various life sciences and technology transactions. Dr. Wang also has extensive experience in China-related cross-border licensing and collaboration, as well as supply and distribution transactions.

While attending law school, Dr. Wang served as the Editor for the Cornell Law Review


Mr. Alan Wang has been recognized by The Best Lawyers in America Ones to Watch for his work in Intellectual Property Law 2022.

In The News









J.D., 2014
Cornell Law School
Ph.D., Chemistry, 2011
Washington University in St. Louis
B.S., Chemistry, Psychology (dual degree), 2006
Peking University



New York
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique